Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Julphar
Fuji
Covington
Deloitte
Colorcon
Farmers Insurance
UBS
QuintilesIMS

Generated: April 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 084902

« Back to Dashboard

NDA 084902 describes PROMETHACON, which is a drug marketed by Polymedica and is included in two NDAs. Additional details are available on the PROMETHACON profile page.

The generic ingredient in PROMETHACON is promethazine hydrochloride. There are twelve drug master file entries for this compound. Seventy suppliers are listed for this compound. Additional details are available on the promethazine hydrochloride profile page.
Summary for 084902
Tradename:PROMETHACON
Applicant:Polymedica
Ingredient:promethazine hydrochloride
Patents:0
Therapeutic Class:Antiemetics
Respiratory Tract Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 084902

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SUPPOSITORY;RECTALStrength50MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
QuintilesIMS
McKinsey
Covington
Harvard Business School
Medtronic
Baxter
Chinese Patent Office
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.